Lipid-modifying enzymes and eicosanoid pathway – substrate-level, non-specific

The term Lipid-modifying enzymes and eicosanoid pathway – substrate-level, non-specific refers to a broad classification of biochemical processes rather than a single, discrete therapeutic target. It encompasses the complex network of enzymes, such as cyclooxygenases (COX), lipoxygenases (LOX), and cytochrome P450 epoxygenases, which convert polyunsaturated fatty acids like arachidonic acid into potent signaling molecules known as eicosanoids. These molecules, including prostaglandins, thromboxanes, and leukotrienes, play critical roles in mediating inflammation, fever, pain, and vascular tone. Because this entry is a high-level pathway descriptor, it is considered 'incorrect' as a specific molecular target for drug discovery purposes. In clinical practice, drugs like non-steroidal anti-inflammatory drugs (NSAIDs) interact with specific enzymes within this pathway to modulate disease states such as chronic inflammation and cardiovascular disorders.

Other names

Eicosanoid pathway (non-specific)Lipid-modifying enzyme substrates

This entry does not represent a single mechanism of action but rather a broad category of biochemical pathways involving the modification of lipid substrates into bioactive eicosanoids.